| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1336 | 2013 |
| Natural history of multiple sclerosis with childhood onset C Renoux, S Vukusic, Y Mikaeloff, G Edan, M Clanet, B Dubois, ... New England Journal of Medicine 356 (25), 2603-2613, 2007 | 721 | 2007 |
| Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study A Cobo-Calvo, A Ruiz, E Maillart, B Audoin, H Zephir, B Bourre, J Ciron, ... Neurology 90 (21), e1858-e1869, 2018 | 447 | 2018 |
| MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomised, double-blind, placebo-controlled study A Tourbah, C Lebrun-Frenay, G Edan, M Clanet, C Papeix, S Vukusic, ... Multiple Sclerosis Journal 22 (13), 1719-1731, 2016 | 344 | 2016 |
| High doses of biotin in chronic progressive multiple sclerosis: a pilot study F Sedel, C Papeix, A Bellanger, V Touitou, C Lebrun-Frenay, D Galanaud, ... Multiple sclerosis and related disorders 4 (2), 159-169, 2015 | 267 | 2015 |
| Neuromyelitis optica in France: a multicenter study of 125 patients N Collongues, R Marignier, H Zephir, C Papeix, F Blanc, C Ritleng, ... Neurology 74 (9), 736-742, 2010 | 258 | 2010 |
| Early CNS neurodegeneration in radiologically isolated syndrome CJ Azevedo, E Overton, S Khadka, J Buckley, S Liu, M Sampat, ... Neuroimmunology & Neuroinflammation 2 (3), e102, 2015 | 220 | 2015 |
| Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects L Grimaldi‐Bensouda, D Guillemot, B Godeau, J Bénichou, ... Journal of Internal Medicine 275 (4), 398-408, 2014 | 190 | 2014 |
| l-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients N Schwab, T Schneider-Hohendorf, V Posevitz, J Breuer, K Göbel, ... Neurology 81 (10), 865-871, 2013 | 171 | 2013 |
| The 11-year long-term follow-up study from the randomized BENEFIT CIS trial L Kappos, G Edan, MS Freedman, X Montalban, HP Hartung, B Hemmer, ... Neurology 87 (10), 978-987, 2016 | 146 | 2016 |
| Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility N Couturier, F Bucciarelli, RN Nurtdinov, M Debouverie, C Lebrun-Frenay, ... Brain 134 (3), 693-703, 2011 | 146 | 2011 |
| Radiologically isolated syndrome: 10‐year risk estimate of a clinical event C Lebrun‐Frenay, O Kantarci, A Siva, MP Sormani, D Pelletier, DT Okuda, ... Annals of neurology 88 (2), 407-417, 2020 | 143 | 2020 |
| Long-term safety and efficacy of teriflunomide: nine-year follow-up of the randomized TEMSO study P O'Connor, G Comi, MS Freedman, AE Miller, L Kappos, JP Bouchard, ... Neurology 86 (10), 920-930, 2016 | 138 | 2016 |
| Neuromyelitis optica and pregnancy B Bourre, R Marignier, H Zephir, C Papeix, D Brassat, G Castelnovo, ... Neurology 78 (12), 875-879, 2012 | 123 | 2012 |
| Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas H Lasolle, C Cortet, F Castinetti, L Cloix, P Caron, B Delemer, ... European Journal of Endocrinology 176 (6), 769-777, 2017 | 121 | 2017 |
| Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome. MC Etienne, JL Formento, C Lebrun-Frenay, J Gioanni, M Chatel, ... Clinical cancer research: an official journal of the American Association …, 1998 | 119 | 1998 |
| DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France MP Sormani, M Salvetti, P Labauge, I Schiavetti, H Zephir, L Carmisciano, ... Annals of clinical and translational neurology 8 (8), 1738-1744, 2021 | 106 | 2021 |
| Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance L Grimaldi-Bensouda, M Rossignol, I Koné-Paut, A Krivitzky, ... Journal of Autoimmunity 79, 84-90, 2017 | 95 | 2017 |
| Sodium intake and multiple sclerosis activity and progression in BENEFIT KC Fitzgerald, KL Munger, HP Hartung, MS Freedman, X Montalbán, ... Annals of neurology 82 (1), 20-29, 2017 | 94 | 2017 |
| Excess mortality in patients with multiple sclerosis starts at 20 years from clinical onset: data from a large-scale French observational study E Leray, S Vukusic, M Debouverie, M Clanet, B Brochet, J Sèze, H Zéphir, ... PloS one 10 (7), e0132033, 2015 | 90 | 2015 |
